{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:57:15Z","timestamp":1793458635526,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03072-x","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:55:14Z","timestamp":1769522114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Design and computational evaluation of a prophylactic and therapeutic multi-epitope vaccine candidate against cervical cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Seyedeh Hamideh","family":"Emadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Rahmanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Baharlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Aghaamoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Sanami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"3072_CR1","unstructured":"World Health Organization (WHO). Cervical cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer. Accessed 13th June 2025."},{"key":"3072_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virusres.2016.12.017","volume":"231","author":"N Egawa","year":"2017","unstructured":"Egawa N, Doorbar J. The low-risk papillomaviruses. Virus Res. 2017;231:119\u201327.","journal-title":"Virus Res"},{"key":"3072_CR3","doi-asserted-by":"crossref","first-page":"200313","DOI":"10.1016\/j.tvr.2025.200313","volume":"19","author":"Y Chen","year":"2025","unstructured":"Chen Y, Egawa N, Zheng K, Doorbar J. How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infection. Tumour Virus Res. 2025;19:200313.","journal-title":"Tumour Virus Res"},{"key":"3072_CR4","doi-asserted-by":"crossref","first-page":"21354","DOI":"10.1038\/s41598-025-05514-y","volume":"15","author":"H Ren","year":"2025","unstructured":"Ren H, Xu R, Zhang J. HPV transmission and optimal control of cervical cancer in China. Sci Rep. 2025;15:21354.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"3072_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","volume":"25","author":"J Doorbar","year":"2015","unstructured":"Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Rev Med Virol. 2015;25(Suppl 1):2\u201323.","journal-title":"Rev Med Virol"},{"key":"3072_CR6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2174\/1389557523666230213140641","volume":"23","author":"W Ahmed","year":"2023","unstructured":"Ahmed W, Zaib S, Ullah S, Fatima A, Zaib Z, Haseeb Azam MA, Umar U, Tariq MU, Aslam R, Khan I. Role of human papillomavirus in various cancers: epidemiology, screening and prevention. Mini Rev Med Chem. 2023;23:1079\u201389.","journal-title":"Mini Rev Med Chem"},{"key":"3072_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mrrev.2016.07.002","volume":"772","author":"ME Harden","year":"2017","unstructured":"Harden ME, Munger K. Human papillomavirus molecular biology. Mutat Res-Rev Mutat Res. 2017;772:3\u201312.","journal-title":"Mutat Res-Rev Mutat Res"},{"key":"3072_CR8","doi-asserted-by":"crossref","unstructured":"Yu L, Majerciak V, Zheng ZM. HPV16 and HPV18 genome Structure, Expression, and Post-Transcriptional regulation. Int J Mol Sci 2022, 23.","DOI":"10.3390\/ijms23094943"},{"key":"3072_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/v9070180","volume":"9","author":"R Katzenellenbogen","year":"2017","unstructured":"Katzenellenbogen R. Telomerase induction in HPV infection and oncogenesis. Viruses. 2017;9:180.","journal-title":"Viruses"},{"key":"3072_CR10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4172\/1747-0862.1000216","volume":"10","author":"P Gariglio","year":"2016","unstructured":"Gariglio P, Organista-Nava J, Alvarez-Rios E. Role of HR-HPVs E6 and E7 oncoproteins in cervical carcinogenesis. J Mol Genet Med. 2016;10:1747\u20130862.","journal-title":"J Mol Genet Med"},{"key":"3072_CR11","doi-asserted-by":"crossref","first-page":"e1012914","DOI":"10.1371\/journal.ppat.1012914","volume":"21","author":"A Avenhaus","year":"2025","unstructured":"Avenhaus A, Velimirovi\u0107 M, Bulkescher J, Scheffner M, Hoppe-Seyler F, Hoppe-Seyler K. E6AP is essential for the proliferation of HPV-positive cancer cells by preventing senescence. PLoS Pathog. 2025;21:e1012914.","journal-title":"PLoS Pathog"},{"key":"3072_CR12","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29:946\u201360.","journal-title":"Cell Death Differ"},{"key":"3072_CR13","doi-asserted-by":"crossref","first-page":"001540","DOI":"10.1099\/jgv.0.001540","volume":"102","author":"JA Scarth","year":"2021","unstructured":"Scarth JA, Patterson MR, Morgan EL, Macdonald A. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation. J Gen Virol. 2021;102:001540.","journal-title":"J Gen Virol"},{"key":"3072_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrrev.2016.09.004","volume":"772","author":"P Aksoy","year":"2017","unstructured":"Aksoy P, Gottschalk EY, Meneses PI. HPV entry into cells. Mutat Res Rev Mutat Res. 2017;772:13\u201322.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"3072_CR15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.oraloncology.2017.02.024","volume":"67","author":"H Mirghani","year":"2017","unstructured":"Mirghani H, Sturgis EM, Aup\u00e9rin A, Monsonego J, Blanchard P. Is there an increased risk of cancer among spouses of patients with an HPV-related cancer? A systematic review. Oral Oncol. 2017;67:138\u201345.","journal-title":"Oral Oncol"},{"key":"3072_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftz048","author":"N Hemmat","year":"2019","unstructured":"Hemmat N, Bannazadeh Baghi H. Association of human papillomavirus infection and inflammation in cervical cancer. Pathog Dis. 2019. https:\/\/doi.org\/10.1093\/femspd\/ftz048.","journal-title":"Pathog Dis"},{"key":"3072_CR17","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2174\/1389201020666190802115722","volume":"20","author":"S Vashisht","year":"2019","unstructured":"Vashisht S, Mishra H, Mishra PK, Ekielski A, Talegaonkar S. Structure, genome, infection cycle and clinical manifestations associated with human papillomavirus. Curr Pharm Biotechnol. 2019;20:1260\u201380.","journal-title":"Curr Pharm Biotechnol"},{"key":"3072_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/microorganisms7070199","volume":"7","author":"R Wakabayashi","year":"2019","unstructured":"Wakabayashi R, Nakahama Y, Nguyen V, Espinoza JL. The host-microbe interplay in human Papillomavirus-Induced carcinogenesis. Microorganisms. 2019;7:199.","journal-title":"Microorganisms"},{"key":"3072_CR19","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1002\/jmv.26690","volume":"93","author":"S Li","year":"2021","unstructured":"Li S, Ye M, Chen Y, Gong Q, Mei B. Genetic variation of E6 and E7 genes of human papillomavirus 52 from central China. J Med Virol. 2021;93:3849\u201356.","journal-title":"J Med Virol"},{"key":"3072_CR20","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1002\/jmv.27858","volume":"94","author":"S Duvlis","year":"2022","unstructured":"Duvlis S, Dabeski D, Hiljadnikova-Bajro M, Osmani D, Memeti S. HPV e6\/e7mrna association with Interleukin 10 (rs1800872) polymorphism in a group of Macedonian women. J Med Virol. 2022;94:4485\u20139.","journal-title":"J Med Virol"},{"key":"3072_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040568","author":"P Olczak","year":"2020","unstructured":"Olczak P, Roden RBS. Progress in L2-based prophylactic vaccine development for protection against diverse human papillomavirus genotypes and associated diseases. Vaccines. 2020. https:\/\/doi.org\/10.3390\/vaccines8040568.","journal-title":"Vaccines"},{"key":"3072_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12060689","author":"Z Han","year":"2024","unstructured":"Han Z, Wang S, Mu T, Zhao P, Song L, Zhang Y, et al. Vaccination with a human papillomavirus L2 multimer provides broad protection against 17 human papillomavirus types in the mouse cervicovaginal challenge model. Vaccines. 2024. https:\/\/doi.org\/10.3390\/vaccines12060689.","journal-title":"Vaccines"},{"key":"3072_CR23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virusres.2016.11.020","volume":"231","author":"C Schellenbacher","year":"2017","unstructured":"Schellenbacher C, Roden RBS, Kirnbauer R. Developments in l2-based human papillomavirus (HPV) vaccines. Virus Res. 2017;231:166\u201375.","journal-title":"Virus Res"},{"key":"3072_CR24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/fcp.12690","volume":"35","author":"A Namvar","year":"2021","unstructured":"Namvar A, Bolhassani A, Javadi G, Noormohammadi Z. Combination of human papillomaviruses l1 and l2 multiepitope constructs protects mice against tumor cells. Fundam Clin Pharmacol. 2021;35:1055\u201368.","journal-title":"Fundam Clin Pharmacol"},{"key":"3072_CR25","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1016\/j.vaccine.2010.04.039","volume":"28","author":"S Jagu","year":"2010","unstructured":"Jagu S, Kwak K, Garcea RL, Roden RB. Vaccination with multimeric l2 fusion protein and l1 vlp or capsomeres to broaden protection against HPV infection. Vaccine. 2010;28:4478\u201386.","journal-title":"Vaccine"},{"key":"3072_CR26","doi-asserted-by":"crossref","first-page":"e2337","DOI":"10.1002\/rmv.2337","volume":"33","author":"M Wierzbicka","year":"2023","unstructured":"Wierzbicka M, San Giorgi MR, Dikkers FG. Transmission and clearance of human papillomavirus infection in the oral cavity and its role in oropharyngeal carcinoma\u2013A review. Rev Med Virol. 2023;33:e2337.","journal-title":"Rev Med Virol"},{"key":"3072_CR27","doi-asserted-by":"crossref","first-page":"e2537","DOI":"10.1002\/rmv.2537","volume":"34","author":"J Wolf","year":"2024","unstructured":"Wolf J, Kist LF, Pereira SB, Quessada MA, Petek H, Pille A, Maccari JG, Mutlaq MP, Nasi LA. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Rev Med Virol. 2024;34:e2537.","journal-title":"Rev Med Virol"},{"key":"3072_CR28","doi-asserted-by":"crossref","first-page":"22249","DOI":"10.1038\/s41598-023-48222-1","volume":"13","author":"X Wei","year":"2023","unstructured":"Wei X, Zhang J, Mei Y, Dai Q, Yang X, Wang X. Prevalence and genotype distribution of HPV6\/11\/16\/18 infections among 180,276 outpatient females from a women\u2019s and children\u2019s central Hospital, 2015\u20132021, Chengdu, China. Sci Rep. 2023;13:22249.","journal-title":"Sci Rep"},{"key":"3072_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2013.06.007","volume":"445","author":"HA Cubie","year":"2013","unstructured":"Cubie HA. Diseases associated with human papillomavirus infection. Virology. 2013;445:21\u201334.","journal-title":"Virology"},{"key":"3072_CR30","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"SV Graham","year":"2017","unstructured":"Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci. 2017;131:2201\u201321.","journal-title":"Clin Sci"},{"key":"3072_CR31","doi-asserted-by":"crossref","first-page":"649815","DOI":"10.3389\/fcimb.2021.649815","volume":"11","author":"J Rs","year":"2021","unstructured":"Rs J. The immune microenvironment in human papilloma virus-induced cervical lesions\u2014Evidence for Estrogen as an Immunomodulator. Front Cell Infect Microbiol. 2021;11:649815.","journal-title":"Front Cell Infect Microbiol"},{"key":"3072_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/v9090261","author":"C Moody","year":"2017","unstructured":"Moody C. Mechanisms by which HPV induces a replication competent environment in differentiating keratinocytes. Viruses. 2017. https:\/\/doi.org\/10.3390\/v9090261.","journal-title":"Viruses"},{"key":"3072_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/v13020321","volume":"13","author":"AN Della Fera","year":"2021","unstructured":"Della Fera AN, Warburton A, Coursey TL, Khurana S, McBride AA. Persistent human papillomavirus infection. Viruses. 2021;13:321.","journal-title":"Viruses"},{"key":"3072_CR34","doi-asserted-by":"crossref","first-page":"fuad004","DOI":"10.1093\/femsre\/fuad004","volume":"47","author":"SJ Goodswen","year":"2023","unstructured":"Goodswen SJ, Kennedy PJ, Ellis JT. A guide to current methodology and usage of reverse vaccinology towards in Silico vaccine discovery. FEMS Microbiol Rev. 2023;47:fuad004.","journal-title":"FEMS Microbiol Rev"},{"key":"3072_CR35","doi-asserted-by":"crossref","unstructured":"Felice AG, Lemes MR, Junior AC, Jaiswal AK, Sousa EG, de Paula JA, San Wu MM, Marques PH, Tiveron RDR, Ceballos VAS. Fundamentals of reverse vaccinology: history and advantages over the discovery of conventional vaccine candidates. In Reverse Vaccinology. Elsevier; 2024: 3\u201329.","DOI":"10.1016\/B978-0-443-13395-4.00004-6"},{"key":"3072_CR36","doi-asserted-by":"crossref","unstructured":"Felice AG, Lemes MR, Junior AC, Jaiswal AK, Sousa EG, de Paula JA, Wu MMS, Marques PH, Tiveron RDR, Ceballos VAS et al. Chap. 1 - Fundamentals of reverse vaccinology: history and advantages over the discovery of conventional vaccine candidates. In Reverse Vaccinology. Edited by Das J, Dave S, Soares SdC, Tiwari S: Academic Press; 2024: 3\u201329.","DOI":"10.1016\/B978-0-443-13395-4.00004-6"},{"key":"3072_CR37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","volume":"11","author":"Y Yang","year":"2015","unstructured":"Yang Y, Sun W, Guo J, Zhao G, Sun S, Yu H, et al. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Hum Vaccines Immunother. 2015;11:795\u2013805.","journal-title":"Hum Vaccines Immunother"},{"key":"3072_CR38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12864-023-09330-4","volume":"24","author":"H Sher","year":"2023","unstructured":"Sher H, Sharif H, Zaheer T, Khan SA, Ali A, Javed H, Javed A. Employing computational tools to design a multi-epitope vaccine targeting human immunodeficiency virus-1 (HIV-1). BMC Genomics. 2023;24:276.","journal-title":"BMC Genomics"},{"key":"3072_CR39","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.vaccine.2018.03.042","volume":"36","author":"RK Pandey","year":"2018","unstructured":"Pandey RK, Ojha R, Aathmanathan VS, Krishnan M, Prajapati VK. Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection. Vaccine. 2018;36:2262\u201372.","journal-title":"Vaccine"},{"key":"3072_CR40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12985-025-02764-0","volume":"22","author":"SK Mishra","year":"2025","unstructured":"Mishra SK, Guendouzi A, Kumar N, Sharma G, Alqahtani T, Zaki MEA, Al mashud MA, Tiruneh YK, Georrge JJ. Integrated Immuno and bioinformatics assisted novel epitope vaccine against HIV infection: a study based on complete genome. Virol J. 2025;22:228.","journal-title":"Virol J"},{"key":"3072_CR41","doi-asserted-by":"crossref","first-page":"1540253","DOI":"10.3389\/fimmu.2025.1540253","volume":"16","author":"S Kumar Mishra","year":"2025","unstructured":"Kumar Mishra S, Kumar N, Or Rashid MH, Sultana S, Dawoud TM, Bourhia M, Georrge JJ. An integrated mutation-based immunoinformatic approach incorporating variability in epitopes: a study based on HIV subtype C. Front Immunol. 2025;16:1540253.","journal-title":"Front Immunol"},{"key":"3072_CR42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12985-022-01939-3","volume":"19","author":"H Zhu","year":"2022","unstructured":"Zhu H, Liu X, Wu Y, He Y, Zheng H, Liu H, Liu Q. Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10. Virol J. 2022;19:203.","journal-title":"Virol J"},{"key":"3072_CR43","doi-asserted-by":"crossref","first-page":"127883","DOI":"10.1016\/j.molliq.2025.127883","volume":"433","author":"SK Mishra","year":"2025","unstructured":"Mishra SK, Siddiquee NH, Patel CN, Kumar N, Senathilake KS, Georrge JJ. Integrated immunoinformatics and reverse vaccinology assisted novel multi-epitope vaccine against coxsackievirus A10 investigating its whole genome encoded polyprotein. J Mol Liq. 2025;433:127883.","journal-title":"J Mol Liq"},{"key":"3072_CR44","doi-asserted-by":"crossref","first-page":"933594","DOI":"10.3389\/fimmu.2022.933594","volume":"13","author":"S Huang","year":"2022","unstructured":"Huang S, Zhang C, Li J, Dai Z, Huang J, Deng F, Wang X, Yue X, Hu X, Li Y. Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches. Front Immunol. 2022;13:933594.","journal-title":"Front Immunol"},{"key":"3072_CR45","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1038\/s41598-021-81749-9","volume":"11","author":"Z Yang","year":"2021","unstructured":"Yang Z, Bogdan P, Nazarian S. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Sci Rep. 2021;11:3238.","journal-title":"Sci Rep"},{"key":"3072_CR46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/07391102.2020.1792347","volume":"40","author":"A Samad","year":"2022","unstructured":"Samad A, Ahammad F, Nain Z, Alam R, Imon RR, Hasan M, et al. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. J Biomol Struct Dyn. 2022;40:14\u201330.","journal-title":"J Biomol Struct Dyn"},{"key":"3072_CR47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bj.2020.09.005","volume":"44","author":"HX Lim","year":"2021","unstructured":"Lim HX, Lim J, Jazayeri SD, Poppema S, Poh CL. Development of multi-epitope peptide-based vaccines against SARS-CoV-2. Biomed J. 2021;44:18\u201330.","journal-title":"Biomed J"},{"key":"3072_CR48","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1038\/s41598-020-67749-1","volume":"10","author":"T Kar","year":"2020","unstructured":"Kar T, Narsaria U, Basak S, Deb D, Castiglione F, Mueller DM, Srivastava AP. A candidate multi-epitope vaccine against SARS-CoV-2. Sci Rep. 2020;10:10895.","journal-title":"Sci Rep"},{"key":"3072_CR49","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1080\/07391102.2020.1770127","volume":"39","author":"K Abraham Peele","year":"2021","unstructured":"Abraham Peele K, Srihansa T, Krupanidhi S, Ayyagari VS, Venkateswarulu T. Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study. J Biomol Struct Dynamics. 2021;39:3793\u2013801.","journal-title":"J Biomol Struct Dynamics"},{"key":"3072_CR50","doi-asserted-by":"crossref","first-page":"24485","DOI":"10.1038\/s41598-021-03932-2","volume":"11","author":"H Tarrahimofrad","year":"2021","unstructured":"Tarrahimofrad H, Rahimnahal S, Zamani J, Jahangirian E, Aminzadeh S. Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9. Sci Rep. 2021;11:24485.","journal-title":"Sci Rep"},{"key":"3072_CR51","doi-asserted-by":"crossref","first-page":"152053","DOI":"10.1016\/j.imbio.2021.152053","volume":"226","author":"S Sharma","year":"2021","unstructured":"Sharma S, Kumari V, Kumbhar BV, Mukherjee A, Pandey R, Kondabagil K. Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of influenza A virus. Immunobiology. 2021;226:152053.","journal-title":"Immunobiology"},{"key":"3072_CR52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12859-022-04581-6","volume":"22","author":"A Maleki","year":"2021","unstructured":"Maleki A, Russo G, Parasiliti Palumbo GA, Pappalardo F. In silico design of recombinant multi-epitope vaccine against influenza A virus. BMC Bioinformatics. 2021;22:617.","journal-title":"BMC Bioinformatics"},{"key":"3072_CR53","doi-asserted-by":"crossref","first-page":"1474346","DOI":"10.3389\/fimmu.2024.1474346","volume":"15","author":"J-S Yun","year":"2024","unstructured":"Yun J-S, Kim AR, Kim SM, Shin E, Ha S-J, Kim D, Jeong H-S. In Silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosis. Front Immunol. 2024;15:1474346.","journal-title":"Front Immunol"},{"key":"3072_CR54","doi-asserted-by":"crossref","first-page":"15923","DOI":"10.1038\/s41598-024-66858-5","volume":"14","author":"G Sethi","year":"2024","unstructured":"Sethi G, Varghese RP, Lakra AK, Nayak SS, Krishna R, Hwang JH. Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis. Sci Rep. 2024;14:15923.","journal-title":"Sci Rep"},{"key":"3072_CR55","doi-asserted-by":"crossref","first-page":"e0275749","DOI":"10.1371\/journal.pone.0275749","volume":"17","author":"N Bolourchi","year":"2022","unstructured":"Bolourchi N, Fereshteh S, Noori Goodarzi N, Badmasti F. Subtractive genomic analysis for computational identification of putative immunogenic targets against clinical Enterobacter cloacae complex. PLoS One. 2022;17:e0275749.","journal-title":"PLoS One"},{"key":"3072_CR56","doi-asserted-by":"crossref","first-page":"1454394","DOI":"10.3389\/fimmu.2024.1454394","volume":"15","author":"HH Alhassan","year":"2024","unstructured":"Alhassan HH. Advanced vaccinomic, immunoinformatic, and molecular modeling strategies for designing Multi-epitope vaccines against the Enterobacter cloacae complex. Front Immunol. 2024;15:1454394.","journal-title":"Front Immunol"},{"key":"3072_CR57","doi-asserted-by":"crossref","first-page":"111212","DOI":"10.1016\/j.humimm.2024.111212","volume":"86","author":"PA Sarabi","year":"2025","unstructured":"Sarabi PA, Rismani E, Shabanpouremam M, Talehahmad S, Vosough M. Developing a multi-epitope vaccine against Helicobacter pylori. Hum Immunol. 2025;86:111212.","journal-title":"Hum Immunol"},{"key":"3072_CR58","doi-asserted-by":"crossref","first-page":"e0318750","DOI":"10.1371\/journal.pone.0318750","volume":"20","author":"M Nahian","year":"2025","unstructured":"Nahian M, Khan MR, Rahman F, Reza HM, Bayil I, Nodee TA, Basher T, Sany MR, Munmun RN, Habib SA. Immunoinformatic strategy for developing multi-epitope subunit vaccine against Helicobacter pylori. PLoS ONE. 2025;20:e0318750.","journal-title":"PLoS ONE"},{"key":"3072_CR59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.meegid.2017.02.007","volume":"49","author":"B Meza","year":"2017","unstructured":"Meza B, Ascencio F, Sierra-Beltr\u00e1n AP, Torres J, Angulo C. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: an in silico approach. Infect Genet Evol. 2017;49:309\u201317.","journal-title":"Infect Genet Evol"},{"key":"3072_CR60","doi-asserted-by":"crossref","first-page":"1432968","DOI":"10.3389\/fimmu.2024.1432968","volume":"15","author":"M Cui","year":"2024","unstructured":"Cui M, Ji X, Guan F, Su G, Du L. Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics. Front Immunol. 2024;15:1432968.","journal-title":"Front Immunol"},{"key":"3072_CR61","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijbiomac.2018.08.125","volume":"120","author":"B Vakili","year":"2018","unstructured":"Vakili B, Eslami M, Hatam GR, Zare B, Erfani N, Nezafat N, et al. Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum. Int J Biol Macromol. 2018;120:1127\u201339.","journal-title":"Int J Biol Macromol"},{"key":"3072_CR62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11756-021-00934-3","volume":"77","author":"M Shams","year":"2022","unstructured":"Shams M, Nourmohammadi H, Majidiani H, Shariatzadeh SA, Asghari A, Fatollahzadeh M, et al. Engineering a multi-epitope vaccine candidate against Leishmania infantum using comprehensive immunoinformatics methods. Biologia. 2022;77:277\u201389.","journal-title":"Biologia"},{"key":"3072_CR63","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/vaccines10091389","volume":"10","author":"M Hammed-Akanmu","year":"2022","unstructured":"Hammed-Akanmu M, Mim M, Osman AY, Sheikh AM, Behmard E, Rabaan AA, et al. Designing a multi-epitope vaccine against Toxoplasma gondii: an immunoinformatics approach. Vaccines. 2022;10:1389.","journal-title":"Vaccines"},{"key":"3072_CR64","doi-asserted-by":"crossref","first-page":"111655","DOI":"10.1016\/j.molbiopara.2024.111655","volume":"260","author":"N Ahmed","year":"2024","unstructured":"Ahmed N, Rani NA, Robin TB, Mashrur MN, Shovo MMI, Prome AA, Sultana S, Akhand MRN. Designing a multi-epitope subunit vaccine against Toxoplasma gondii through reverse vaccinology approach. Mol Biochem Parasitol. 2024;260:111655.","journal-title":"Mol Biochem Parasitol"},{"key":"3072_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121413","author":"S Kamolratanakul","year":"2021","unstructured":"Kamolratanakul S, Pitisuttithum P. Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccines (Basel). 2021. https:\/\/doi.org\/10.3390\/vaccines9121413.","journal-title":"Vaccines (Basel)"},{"key":"3072_CR66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13027-025-00643-5","volume":"20","author":"S Amiri","year":"2025","unstructured":"Amiri S, Rasekh S, Moezzi SMI, Seifi N, Fatemi SA, Fathi S, Bagheri A, Negahdaripour M. Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded. Infect Agent Cancer. 2025;20:16.","journal-title":"Infect Agent Cancer"},{"key":"3072_CR67","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/aogs.14359","volume":"101","author":"DO Eriksen","year":"2022","unstructured":"Eriksen DO, Jensen PT, Schroll JB, Hammer A. Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2022;101:597\u2013607.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3072_CR68","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/ijmr.IJMR_4240_20","volume":"154","author":"P Poddar","year":"2021","unstructured":"Poddar P, Maheshwari A. Surgery for cervical cancer: consensus & controversies. Indian J Med Res. 2021;154:284\u201392.","journal-title":"Indian J Med Res"},{"key":"3072_CR69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393:169\u201382.","journal-title":"Lancet"},{"key":"3072_CR70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-62703-646-7_6","volume":"1079","author":"F Sievers","year":"2014","unstructured":"Sievers F, Higgins DG. Clustal omega, accurate alignment of very large numbers of sequences. Methods Mol Biol. 2014;1079:105\u201316.","journal-title":"Methods Mol Biol"},{"key":"3072_CR71","doi-asserted-by":"crossref","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","volume":"53","author":"R Vita","year":"2025","unstructured":"Vita R, Blazeska N, Marrama D, Duesing S, Bennett J, Greenbaum J, De Almeida Mendes M, Mahita J, Wheeler DK, Cantrell JR, et al. The immune epitope database (IEDB): 2024 update. Nucleic Acids Res. 2025;53:D436\u201343.","journal-title":"Nucleic Acids Res"},{"key":"3072_CR72","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 2020;48:W449-54.","journal-title":"Nucleic Acids Res"},{"key":"3072_CR73","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen MC, Peters B, Nielsen M, Marcatili P. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017;45:W24\u20139.","journal-title":"Nucleic Acids Res"},{"key":"3072_CR74","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.vaccine.2006.09.032","volume":"25","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. Vaccine. 2007;25:856\u201366.","journal-title":"Vaccine"},{"key":"3072_CR75","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8:4.","journal-title":"BMC Bioinformatics"},{"key":"3072_CR76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1875035400801010022","volume":"1","author":"IA Doytchinova","year":"2008","unstructured":"Doytchinova IA, Flower DR. Bioinformatic approach for identifying parasite and fungal candidate subunit vaccines. Open Vaccine J. 2008;1:4.","journal-title":"Open Vaccine J"},{"key":"3072_CR77","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP v.2\u2013a server for in Silico prediction of allergens. J Mol Model. 2014;20:2278.","journal-title":"J Mol Model"},{"key":"3072_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020431","author":"V Morozov","year":"2023","unstructured":"Morozov V, Rodrigues CHM, Ascher DB. CSM-toxin: a web-server for predicting protein toxicity. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15020431.","journal-title":"Pharmaceutics"},{"key":"3072_CR79","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/JVI.75.2.654-660.2001","volume":"75","author":"U Dittmer","year":"2001","unstructured":"Dittmer U, Peterson KE, Messer R, Stromnes IM, Race B, Hasenkrug KJ. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to friend retrovirus infection. J Virol. 2001;75:654\u201360.","journal-title":"J Virol"},{"key":"3072_CR80","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.4049\/jimmunol.175.9.5931","volume":"175","author":"LK Teixeira","year":"2005","unstructured":"Teixeira LK, Fonseca BP, Vieira-de-Abreu A, Barboza BA, Robbs BK, Bozza PT, Viola JP. IFN-gamma production by CD8\u2009+\u2009T cells depends on NFAT1 transcription factor and regulates Th differentiation. J Immunol. 2005;175:5931\u20139.","journal-title":"J Immunol"},{"key":"3072_CR81","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.4049\/jimmunol.1302379","volume":"193","author":"C Wu","year":"2014","unstructured":"Wu C, Xue Y, Wang P, Lin L, Liu Q, Li N, Xu J, Cao X. IFN-\u03b3 primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b. J Immunol. 2014;193:3036\u201344.","journal-title":"J Immunol"},{"key":"3072_CR82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda SK, Vir P, Raghava GP. Designing of interferon-gamma inducing MHC class-II binders. Biol Direct. 2013;8:30.","journal-title":"Biol Direct"},{"key":"3072_CR83","doi-asserted-by":"crossref","first-page":"104703","DOI":"10.1016\/j.compbiomed.2021.104703","volume":"136","author":"AA Saba","year":"2021","unstructured":"Saba AA, Adiba M, Saha P, Hosen MI, Chakraborty S, Nabi AHMN. An in-depth in Silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest. Comput Biol Med. 2021;136:104703.","journal-title":"Comput Biol Med"},{"key":"3072_CR84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"HH Bui","year":"2006","unstructured":"Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics. 2006;7:153.","journal-title":"BMC Bioinformatics"},{"key":"3072_CR85","doi-asserted-by":"crossref","first-page":"e13677","DOI":"10.1371\/journal.pone.0013677","volume":"5","author":"RN Coler","year":"2010","unstructured":"Coler RN, Baldwin SL, Shaverdian N, Bertholet S, Reed SJ, Raman VS, et al. A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS One. 2010;5:e13677.","journal-title":"PLoS One"},{"key":"3072_CR86","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-61737-967-3_16","volume":"705","author":"P Sun","year":"2011","unstructured":"Sun P, Tropea JE, Waugh DS. Enhancing the solubility of recombinant proteins in Escherichia coli by using hexahistidine-tagged maltose-binding protein as a fusion partner. Methods Mol Biol. 2011;705:259\u201374.","journal-title":"Methods Mol Biol"},{"key":"3072_CR87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/yea.1431","volume":"24","author":"M Sabourin","year":"2007","unstructured":"Sabourin M, Tuzon CT, Fisher TS, Zakian VA. A flexible protein linker improves the function of epitope-tagged proteins in Saccharomyces cerevisiae. Yeast. 2007;24:39\u201345.","journal-title":"Yeast"},{"key":"3072_CR88","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.vaccine.2005.01.031","volume":"23","author":"A Yano","year":"2005","unstructured":"Yano A, Onozuka A, Asahi-Ozaki Y, Imai S, Hanada N, Miwa Y, Nisizawa T. An ingenious design for peptide vaccines. Vaccine. 2005;23:2322\u20136.","journal-title":"Vaccine"},{"key":"3072_CR89","doi-asserted-by":"crossref","unstructured":"Arai R. Chapter Eight - Design of helical linkers for fusion proteins and protein-based nanostructures. In: Merkx M, editor. Methods in Enzymology. Volume, vol. 647. Academic Press; 2021. p. 209\u201330.","DOI":"10.1016\/bs.mie.2020.10.003"},{"key":"3072_CR90","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/protein\/14.8.529","volume":"14","author":"R Arai","year":"2001","unstructured":"Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 2001;14:529\u201332.","journal-title":"Protein Eng"},{"key":"3072_CR91","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","volume":"26","author":"CN Magnan","year":"2010","unstructured":"Magnan CN, Zeller M, Kayala MA, Vigil A, Randall A, Felgner PL, Baldi P. High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics. 2010;26:2936\u201343.","journal-title":"Bioinformatics"},{"key":"3072_CR92","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch M, Carballo-Amador MA, Charonis S, Curtis R, Warwicker J. Protein-Sol: a web tool for predicting protein solubility from sequence. Bioinformatics. 2017;33:3098\u2013100.","journal-title":"Bioinformatics"},{"key":"3072_CR93","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","volume":"25","author":"CN Magnan","year":"2009","unstructured":"Magnan CN, Randall A, Baldi P. SOLpro: accurate sequence-based prediction of protein solubility. Bioinformatics. 2009;25:2200\u20137.","journal-title":"Bioinformatics"},{"key":"3072_CR94","doi-asserted-by":"crossref","unstructured":"Walker JM. The proteomics protocols handbook. Springer; 2005.","DOI":"10.1385\/1592598900"},{"key":"3072_CR95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0968-0004(99)01540-6","volume":"25","author":"C Combet","year":"2000","unstructured":"Combet C, Blanchet C, Geourjon C, Deleage G. NPS@: network protein sequence analysis. Trends Biochem Sci. 2000;25:147\u201350.","journal-title":"Trends Biochem Sci"},{"key":"3072_CR96","doi-asserted-by":"crossref","unstructured":"Garnier J, Gibrat J-F, Robson B. [32] GOR method for predicting protein secondary structure from amino acid sequence. Methods in enzymology. Volume 266. Elsevier; 1996. pp. 540\u201353.","DOI":"10.1016\/S0076-6879(96)66034-0"},{"key":"3072_CR97","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2105-13-198","volume":"13","author":"J Ko","year":"2012","unstructured":"Ko J, Park H, Seok C. GalaxyTBM: template-based modeling by building a reliable core and refining unreliable local regions. BMC Bioinformatics. 2012;13:198.","journal-title":"BMC Bioinformatics"},{"key":"3072_CR98","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo L, Park H, Seok C. GalaxyRefine: protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 2013;41:W384\u2013388.","journal-title":"Nucleic Acids Res"},{"key":"3072_CR99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. Appl Crystallogr. 1993;26:283\u201391.","journal-title":"Appl Crystallogr"},{"key":"3072_CR100","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35:W407\u2013410.","journal-title":"Nucleic Acids Res"},{"key":"3072_CR101","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/prot.340170404","volume":"17","author":"MJ Sippl","year":"1993","unstructured":"Sippl MJ. Recognition of errors in three-dimensional structures of proteins. Proteins. 1993;17:355\u201362.","journal-title":"Proteins"},{"key":"3072_CR102","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko J, Bui HH, Li W, Fusseder N, Bourne PE, Sette A, Peters B. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics. 2008;9:514.","journal-title":"BMC Bioinformatics"},{"key":"3072_CR103","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1471-2105-14-346","volume":"14","author":"DB Craig","year":"2013","unstructured":"Craig DB, Dombkowski AA. Disulfide by design 2.0: a web-based tool for disulfide engineering in proteins. BMC Bioinformatics. 2013;14:346.","journal-title":"BMC Bioinformatics"},{"key":"3072_CR104","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/bioinformatics\/btg231","volume":"19","author":"AA Dombkowski","year":"2003","unstructured":"Dombkowski AA. Disulfide by design: a computational method for the rational design of disulfide bonds in proteins. Bioinformatics. 2003;19:1852\u20133.","journal-title":"Bioinformatics"},{"key":"3072_CR105","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.str.2020.06.006","volume":"28","author":"IT Desta","year":"2020","unstructured":"Desta IT, Porter KA, Xia B, Kozakov D, Vajda S. Performance and its limits in rigid body Protein-Protein Docking. Structure. 2020;28:1071\u2013e10811073.","journal-title":"Structure"},{"key":"3072_CR106","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1107\/S2059798322002741","volume":"78","author":"G Jones","year":"2022","unstructured":"Jones G, Jindal A, Ghani U, Kotelnikov S, Egbert M, Hashemi N, et al. Elucidation of protein function using computational docking and hotspot analysis by cluspro and ftmap. Acta Crystallogr D Struct Biol. 2022;78:690\u20137.","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"3072_CR107","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/prot.24403","volume":"81","author":"D Kozakov","year":"2013","unstructured":"Kozakov D, Beglov D, Bohnuud T, Mottarella SE, Xia B, Hall DR, Vajda S. How good is automated protein docking? Proteins. 2013;81:2159\u201366.","journal-title":"Proteins"},{"key":"3072_CR108","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. The cluspro web server for protein-protein docking. Nat Protoc. 2017;12:255\u201378.","journal-title":"Nat Protoc"},{"key":"3072_CR109","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/prot.25219","volume":"85","author":"S Vajda","year":"2017","unstructured":"Vajda S, Yueh C, Beglov D, Bohnuud T, Mottarella SE, Xia B, Hall DR, Kozakov D. New additions to the cluspro server motivated by CAPRI. Proteins. 2017;85:435\u201344.","journal-title":"Proteins"},{"key":"3072_CR110","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem"},{"key":"3072_CR111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski RA, Jab\u0142o\u0144ska J, Pravda L, Va\u0159ekov\u00e1 RS, Thornton JM. PDBsum: structural summaries of PDB entries. Protein Sci. 2018;27:129\u201334.","journal-title":"Protein Sci"},{"key":"3072_CR112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-4655(95)00041-D","volume":"91","author":"DA Pearlman","year":"1995","unstructured":"Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE, DeBolt S, Ferguson D, Seibel G, Kollman P. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun. 1995;91:1\u201341.","journal-title":"Comput Phys Commun"},{"key":"3072_CR113","volume":"222","author":"J Wang","year":"2001","unstructured":"Wang J, Wang W, Kollman PA, Case DA. Antechamber: an accessory software package for molecular mechanical calculations. J Am Chem Soc. 2001;222:2001.","journal-title":"J Am Chem Soc"},{"key":"3072_CR114","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler V, Van Gunsteren WF, H\u00fcnenberger PH. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem. 2001;22:501\u20138.","journal-title":"J Comput Chem"},{"key":"3072_CR115","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR 3rd, McGee TD Jr., Swails JM, Homeyer N, Gohlke H, Roitberg AE. MMPBSA.py: an efficient program for End-State free energy calculations. J Chem Theory Comput. 2012;8:3314\u201321.","journal-title":"J Chem Theory Comput"},{"key":"3072_CR116","doi-asserted-by":"crossref","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin N, Lund O, Bernaschi M, Castiglione F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. 2010;5:e9862.","journal-title":"PLoS One"},{"key":"3072_CR117","doi-asserted-by":"crossref","first-page":"842329","DOI":"10.1155\/2012\/842329","volume":"2012","author":"F Castiglione","year":"2012","unstructured":"Castiglione F, Mantile F, De Berardinis P, Prisco A. How the interval between prime and boost injection affects the immune response in a computational model of the immune system. Comput Math Methods Med. 2012;2012:842329.","journal-title":"Comput Math Methods Med"},{"key":"3072_CR118","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote A, Hiller K, Scheer M, M\u00fcnch R, N\u00f6rtemann B, Hempel DC, Jahn D. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005;33:W526\u2013531.","journal-title":"Nucleic Acids Res"},{"key":"3072_CR119","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/acsbiomaterials.9b01983","volume":"6","author":"N Cohen","year":"2020","unstructured":"Cohen N, Eisenbach CD. Molecular mechanics of Beta-Sheets. ACS Biomater Sci Eng. 2020;6:1940\u20139.","journal-title":"ACS Biomater Sci Eng"},{"key":"3072_CR120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12985-023-02270-1","volume":"21","author":"A Gholamzad","year":"2024","unstructured":"Gholamzad A, Khakpour N, Hashemi M, Gholamzad M. Prevalence of high and low risk HPV genotypes among vaccinated and non-vaccinated people in Tehran. Virol J. 2024;21:9.","journal-title":"Virol J"},{"key":"3072_CR121","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2017.92","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang L. Multi-epitope vaccines: a promising strategy against tumors and viral infections. Cell Mol Immunol. 2018;15:182\u20134.","journal-title":"Cell Mol Immunol"},{"key":"3072_CR122","doi-asserted-by":"crossref","unstructured":"Prathyusha AMVN, Bramhachari PV. Current Advances in Multi-Epitope Viral Vaccines Development and Research. In: Bramhachari PV, editor. Dynamics of Immune Activation in Viral Diseases. Singapore: Springer Singapore; 2020. p. 277\u201383.","DOI":"10.1007\/978-981-15-1045-8_18"},{"key":"3072_CR123","unstructured":"Aribi M. Development: from traditional to modern approaches. New Top Vaccine Dev 2024, 3."},{"key":"3072_CR124","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s12033-021-00374-z","volume":"63","author":"M Kayyal","year":"2021","unstructured":"Kayyal M, Bolhassani A, Noormohammadi Z, Sadeghizadeh M. In silico design and immunological studies of two novel multiepitope DNA-Based vaccine candidates against High-Risk human papillomaviruses. Mol Biotechnol. 2021;63:1192\u2013222.","journal-title":"Mol Biotechnol"},{"key":"3072_CR125","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1038\/s41598-022-13442-4","volume":"12","author":"A Kumar","year":"2022","unstructured":"Kumar A, Sahu U, Kumari P, Dixit A, Khare P. Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer. Sci Rep. 2022;12:9521.","journal-title":"Sci Rep"},{"key":"3072_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051493","author":"M Shahab","year":"2023","unstructured":"Shahab M, Guo D, Zheng G, Zou Y. Design of a novel and potent multi-epitope chimeric vaccine against human papillomavirus (HPV): an immunoinformatics approach. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11051493.","journal-title":"Biomedicines"},{"key":"3072_CR127","doi-asserted-by":"crossref","first-page":"2352908","DOI":"10.1080\/21645515.2024.2352908","volume":"20","author":"L Zhu","year":"2024","unstructured":"Zhu L, Cui X, Yan Z, Tao Y, Shi L, Zhang X, Yao Y, Shi L. Design and evaluation of a multi-epitope DNA vaccine against HPV16. Hum Vaccin Immunother. 2024;20:2352908.","journal-title":"Hum Vaccin Immunother"},{"key":"3072_CR128","doi-asserted-by":"crossref","first-page":"e0311351","DOI":"10.1371\/journal.pone.0311351","volume":"19","author":"M Ehsasatvatan","year":"2024","unstructured":"Ehsasatvatan M, Baghban Kohnehrouz B. Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types. PLoS One. 2024;19:e0311351.","journal-title":"PLoS One"},{"key":"3072_CR129","first-page":"102135","volume":"43","author":"F Firuzpour","year":"2025","unstructured":"Firuzpour F, Barancheshmeh M, Ziarani FF, Karami L, Aram C. The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation. Biochem Biophys Rep. 2025;43:102135.","journal-title":"Biochem Biophys Rep"},{"key":"3072_CR130","doi-asserted-by":"crossref","first-page":"121393","DOI":"10.1016\/j.biomaterials.2022.121393","volume":"283","author":"I Naqvi","year":"2022","unstructured":"Naqvi I, Giroux N, Olson L, Morrison SA, Llanga T, Akinade TO, Zhu Y, Zhong Y, Bose S, Arvai S, et al. DAMPs\/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists. Biomaterials. 2022;283:121393.","journal-title":"Biomaterials"},{"key":"3072_CR131","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"YC Lu","year":"2008","unstructured":"Lu YC, Yeh WC, Ohashi PS. LPS\/TLR4 signal transduction pathway. Cytokine. 2008;42:145\u201351.","journal-title":"Cytokine"},{"key":"3072_CR132","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11:373\u201384.","journal-title":"Nat Immunol"},{"key":"3072_CR133","doi-asserted-by":"crossref","first-page":"101042831771058","DOI":"10.1177\/1010428317710586","volume":"39","author":"N Jiang","year":"2017","unstructured":"Jiang N, Xie F, Guo Q, Li MQ, Xiao J, Sui L. Toll-like receptor 4 promotes proliferation and apoptosis resistance in human papillomavirus-related cervical cancer cells through the Toll-like receptor 4\/nuclear factor-\u03baB pathway. Tumour Biol. 2017;39:1010428317710586.","journal-title":"Tumour Biol"},{"key":"3072_CR134","doi-asserted-by":"crossref","first-page":"66656","DOI":"10.18632\/oncotarget.19105","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Yang F, Wei F, Ren X. The role of toll-like receptor 4 in tumor microenvironment. Oncotarget. 2017;8:66656\u201367.","journal-title":"Oncotarget"},{"key":"3072_CR135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13027-020-0279-9","volume":"15","author":"N Jiang","year":"2020","unstructured":"Jiang N, Xie F, Chen L, Chen F, Sui L. The effect of TLR4 on the growth and local inflammatory microenvironment of HPV-related cervical cancer in vivo. Infect Agent Cancer. 2020;15:12.","journal-title":"Infect Agent Cancer"},{"key":"3072_CR136","doi-asserted-by":"crossref","first-page":"577823","DOI":"10.3389\/fimmu.2020.577823","volume":"11","author":"YQ Wang","year":"2020","unstructured":"Wang YQ, Bazin-Lee H, Evans JT, Casella CR, Mitchell TC. MPL adjuvant contains competitive antagonists of human TLR4. Front Immunol. 2020;11:577823.","journal-title":"Front Immunol"},{"key":"3072_CR137","doi-asserted-by":"crossref","first-page":"17055","DOI":"10.1038\/sigtrans.2017.55","volume":"2","author":"X Yang","year":"2017","unstructured":"Yang X, Cheng Y, Li C. The role of TLRs in cervical cancer with HPV infection: a review. Signal Transduct Target Ther. 2017;2:17055.","journal-title":"Signal Transduct Target Ther"},{"key":"3072_CR138","doi-asserted-by":"crossref","first-page":"104389","DOI":"10.1016\/j.compbiomed.2021.104389","volume":"132","author":"M Tahir ul Qamar","year":"2021","unstructured":"Tahir ul Qamar M, Ahmad S, Fatima I, Ahmad F, Shahid F, Naz A, Abbasi SW, Khan A, Mirza MU, Ashfaq UA, Chen L-L. Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches. Comput Biol Med. 2021;132:104389.","journal-title":"Comput Biol Med"},{"key":"3072_CR139","doi-asserted-by":"crossref","first-page":"1442101","DOI":"10.3389\/fimmu.2025.1442101","volume":"16","author":"S Mandal","year":"2025","unstructured":"Mandal S, Chanu WP, Natarajaseenivasan K. Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach. Front Immunol. 2025;16:1442101.","journal-title":"Front Immunol"},{"key":"3072_CR140","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvaud Se, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the expasy server. Springer; 2005.","DOI":"10.1385\/1-59259-890-0:571"},{"key":"3072_CR141","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jiph.2014.02.002","volume":"7","author":"S Enany","year":"2014","unstructured":"Enany S. Structural and functional analysis of hypothetical and conserved proteins of clostridium Tetani. J Infect Public Health. 2014;7:296\u2013307.","journal-title":"J Infect Public Health"},{"key":"3072_CR142","first-page":"1895","volume":"88","author":"A Ikai","year":"1980","unstructured":"Ikai A. Thermostability and aliphatic index of globular proteins. J Biochem. 1980;88:1895\u20138.","journal-title":"J Biochem"},{"key":"3072_CR143","doi-asserted-by":"crossref","first-page":"15431","DOI":"10.1038\/s41598-021-92176-1","volume":"11","author":"S Mahmud","year":"2021","unstructured":"Mahmud S, Rafi MO, Paul GK, Promi MM, Shimu MSS, Biswas S, Emran TB, Dhama K, Alyami SA, Moni MA, Saleh MA. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach. Sci Rep. 2021;11:15431.","journal-title":"Sci Rep"},{"key":"3072_CR144","unstructured":"Rehman I. FM BS: Biochemistry, secondary protein structure. StatPearls Publishing: Treasure Island (FL); 2022 ed."},{"key":"3072_CR145","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1021\/jp5013544","volume":"118","author":"N Rawat","year":"2014","unstructured":"Rawat N, Biswas P. Hydrogen bond dynamics in intrinsically disordered proteins. J Phys Chem B. 2014;118:3018\u201325.","journal-title":"J Phys Chem B"},{"key":"3072_CR146","first-page":"101966","volume":"42","author":"G Fatahi","year":"2025","unstructured":"Fatahi G, Abdollahi M, Nashtahosseini Z, Minoo S, Mostafavi M, Saeidi K. Designing of an efficient DC-inducing multi-epitope vaccine against epstein barr virus targeting the GP350 using immunoinformatics and molecular dynamic simulation. Biochem Biophys Rep. 2025;42:101966.","journal-title":"Biochem Biophys Rep"},{"key":"3072_CR147","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12879-024-10343-x","volume":"25","author":"B Bahmani","year":"2025","unstructured":"Bahmani B, Amini-Bayat Z, Ranjbar MM, Makoui MH, Zarnani AH. Development and evaluation of a novel E7 multi-epitopic vaccine for human papillomavirus type 16: design, expression, purification, and immunological characterization. BMC Infect Dis. 2025;25:174.","journal-title":"BMC Infect Dis"},{"key":"3072_CR148","doi-asserted-by":"crossref","first-page":"e0138686","DOI":"10.1371\/journal.pone.0138686","volume":"10","author":"LM de Oliveira","year":"2015","unstructured":"de Oliveira LM, Morale MG, Chaves AA, Cavalher AM, Lopes AS, Diniz Mde O, et al. Design, immune responses and anti-tumor potential of an HPV16 E6E7 multi-epitope vaccine. PLoS One. 2015;10:e0138686.","journal-title":"PLoS One"},{"key":"3072_CR149","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaa008","author":"PD Browne","year":"2020","unstructured":"Browne PD, Nielsen TK, Kot W, Aggerholm A, Gilbert MTP, Puetz L, et al. Gc bias affects genomic and metagenomic reconstructions, underrepresenting GC-poor organisms. Gigascience. 2020. https:\/\/doi.org\/10.1093\/gigascience\/giaa008.","journal-title":"Gigascience"},{"key":"3072_CR150","doi-asserted-by":"crossref","first-page":"17617","DOI":"10.1038\/s41598-020-74091-z","volume":"10","author":"H Fu","year":"2020","unstructured":"Fu H, Liang Y, Zhong X, Pan Z, Huang L, Zhang H, Xu Y, Zhou W, Liu Z. Codon optimization with deep learning to enhance protein expression. Sci Rep. 2020;10:17617.","journal-title":"Sci Rep"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03072-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03072-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03072-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:01:40Z","timestamp":1771423300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03072-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3072"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03072-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical committee of Semnan University of Medical Sciences approved this study with the number: IR.SEMUMS.REC.1403.180.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}